menu
    • menu
    [{"orgOrder":0,"company":"Vivesto","sponsor":"Kazia Therapeutics","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"AUSTRALIA","productType":"Other Small Molecule","year":"2025","type":"Divestment","leadProduct":"Cantrixil","moa":"SMETI","graph1":"Oncology","graph2":"Preclinical","graph3":"Vivesto","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Vivesto \/ Vivesto","highestDevelopmentStatusID":"4","companyTruncated":"Vivesto \/ Vivesto"}]

    Find Clinical Drug Pipeline Developments & Deals by Vivesto

    Menu

    Vivesto

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Vivesto

                            Sweden arrow
                            AACR Annual meeting
                            Not Confirmed

                            Vivesto

                            Sweden arrow
                            AACR Annual meeting
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Cantrixil

                            Therapeutic Area : Oncology

                            Study Phase : Preclinical

                            Recipient : Kazia Therapeutics

                            Deal Size : $1.0 million

                            Deal Type : Divestment

                            DEALS_DEV arrow-down

                            Kazia Sells IP And Trademarks Rights For Cantrixil Asset

                            Details : Vivesto is currently exploring TRX-E-002-1 (cantrixil), a potent and selective third generation benzopyran SMETI inhibitor, preclinically for the treatment of hematological cancers.

                            Product Name : TRXE-002-01

                            Product Type : Other Small Molecule

                            Upfront Cash : Undisclosed

                            March 31, 2025

                            Lead Product(s) : Cantrixil

                            Therapeutic Area : Oncology

                            Highest Development Status : Preclinical

                            Recipient : Kazia Therapeutics

                            Deal Size : $1.0 million

                            Deal Type : Divestment

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth